The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.
about
Leucoreduction of blood components: an effective way to increase blood safety?Transfusion-transmitted CMV infection - current knowledge and future perspectives.AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections.A national review of the clinical use of group O D- red blood cell units.An analysis on the fate of a selection of blood products derived from cytomegalovirus-seronegative donors at three tertiary referral hospitals in Australia.Sequence analysis of two variable cytomegalovirus genes for distinction between transfusion- and breast milk-transmitted infections in a very-low-birthweight infant.
P2860
The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The residual risk of transfusi ...... eucodepleted blood components.
@en
type
label
The residual risk of transfusi ...... eucodepleted blood components.
@en
prefLabel
The residual risk of transfusi ...... eucodepleted blood components.
@en
P2093
P2860
P50
P356
P1433
P1476
The residual risk of transfusi ...... eucodepleted blood components.
@en
P2093
P2860
P356
10.1111/VOX.12250
P577
2015-04-08T00:00:00Z